SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, today announces the appointment of Franois-Henri Reynaud as Chief Financial and Administrative Officer.
Franois-Henri has 13 years experience in finance. For five years, he was initially involved in financing innovative business companies in a financial institution, before overseeing several corporate finance transactions (fund-raising transactions, mergers and acquisitions) as Chief Financial and Administrative Officer of companies in a variety of sectors including medical devices and renewable energies. His most recent appointment was at Global Bioenergies, a listed industrial biology company.
Franois-Henri Reynauds main role will be to handle the Companys financial and administrative affairs, working closely with the Chief Executive Officer.
Franois-Henri Reynaud, Safe Orthopaedics new Chief Financial and Administrative Officer, commented: It is a unique opportunity to join Safe Orthopaedics just as the Company has reported an increase in its third-quarter revenues of over 63% year-on-year and is expanding its business worldwide.
Pierre Dumouchel, Chief Executive Officer and Co-founder of Safe Orthopaedics, added: Together with his expertise in finance, Franois-Henris appointment as Chief Financial and Administrative Officer brings to the table his experience of establishing and building up international subsidiaries just as Safe Orthopaedics embarks on a new phase of expansion to accelerate its growth and business development.
Next financial release: full-year 2017 revenues, Monday, January 15, 2018 (after the market closes)
(c) NNA 2017 LEBANON Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers